The researchers found that heavy drinkers had 133 percent higher odds of developing vascular brain lesions than those who ...

Learn about the impact of Alzheimer's family history on brain resilience and memory function. Your family tree may shape your ...

A study published in The American Journal of Human Genetics by researchers at Baylor College of Medicine and the Jan and Dan ...

Mayo Clinic researchers are studying why some Alzheimer's patients decline rapidly, aiming to find causes, biomarkers, and ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (A?) monoclonal antibody Leqembi® ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD) wh ...

Published in Neurology, the study by McGill University in Montreal, Canada, found that if the father had Alzheimer's disease then the child is highly likely to get diagnosed with ...

Heavy and former heavy drinking is associated with brain abnormalities like hyaline arteriolosclerosis and neurofibrillary ...